Assessment
High-dose omega-3 (EPA) lowers cardiovascular risk in high-risk patients.
?
Conflicting high-grade studies. Strong studies disagree — we show the conflict instead of silently picking a winner.
The strongest supporting evidence is a randomized trial (n=8,179). The strongest contradicting evidence is a randomized trial (n=13,000). High-grade studies disagree, so we show the conflict rather than pick a winner. Strength is the quality-weighted balance of supporting vs contradicting evidence; study quality outweighs sample size.
Strongest counter-evidence (always shown)?
Randomized trial with a different formulation showed no cardiovascular benefit.
Randomized trial · n=13,000
Supporting (2)
Randomized trial showed reduced cardiovascular events at high-dose purified EPA.
Source: REDUCE-IT-type trial
Cohort: higher omega-3 intake associated with fewer events.
Source: Dietary cohort
Contradicting (1)
Randomized trial with a different formulation showed no cardiovascular benefit.
Source: Mixed-formulation RCT
Compare with another assessed claim
$ assess claim cmr1fimmc0004atxfhp99v65uevidence gathered: 3 item(s)support weight=29.52 contradict weight=16.46strength = support / (support + contradict) = 64/100verdict: Mixed evidence [conflict flagged]honesty rule: strongest counter shown
Ask AI
AI can be wrong. Not medical, legal, or financial advice.